GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 320 filers reported holding GLOBUS MED INC in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,795,000 | +587.1% | 121,038 | +803.3% | 0.01% | +450.0% |
| Q1 2022 | $989,000 | -87.1% | 13,400 | -87.4% | 0.00% | -87.5% |
| Q4 2021 | $7,678,000 | +163.7% | 106,353 | +179.8% | 0.02% | +128.6% |
| Q3 2021 | $2,912,000 | +3495.1% | 38,006 | +3550.9% | 0.01% | – |
| Q2 2021 | $81,000 | +102.5% | 1,041 | +61.1% | 0.00% | – |
| Q1 2021 | $40,000 | -68.8% | 646 | -75.0% | 0.00% | -100.0% |
| Q3 2020 | $128,000 | -79.3% | 2,581 | -80.1% | 0.00% | -66.7% |
| Q2 2020 | $619,000 | -71.0% | 12,970 | -64.2% | 0.00% | -57.1% |
| Q4 2019 | $2,133,000 | +347.2% | 36,227 | +287.9% | 0.01% | +250.0% |
| Q3 2019 | $477,000 | +657.1% | 9,340 | +537.1% | 0.00% | – |
| Q4 2018 | $63,000 | -95.7% | 1,466 | -94.4% | 0.00% | -100.0% |
| Q3 2018 | $1,480,000 | – | 26,083 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 197,873 | $11,109,000 | 3.82% |
| Pembroke Management, LTD | 600,148 | $33,692,000 | 3.48% |
| Godshalk Welsh Capital Management, Inc. | 73,101 | $4,104,000 | 2.95% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 688,000 | $38,624,000 | 2.62% |
| XXEC, Inc. | 50,625 | $2,842,000 | 2.26% |
| Van Berkom & Associates Inc. | 885,922 | $49,736,000 | 2.08% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,351,998 | $75,901,000 | 1.75% |
| RTW INVESTMENTS, LP | 1,121,527 | $62,963,000 | 1.63% |
| Global Alpha Capital Management Ltd. | 257,131 | $14,435,000 | 1.56% |
| Ophir Asset Management Pty Ltd | 258,889 | $6,622,381,000 | 1.36% |